INDEGENE
Back to Cashflow Statement
|
INDEGENE Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹288 Cr | ₹-66 Cr | ₹333 Cr | ₹233 Cr | ₹-132 Cr |
What is the latest Cash Flow from Financing Activities ratio of INDEGENE ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹288 Cr |
| Mar2024 | ₹-66 Cr |
| Mar2023 | ₹333 Cr |
| Mar2022 | ₹233 Cr |
| Mar2021 | ₹-132 Cr |
How is Cash Flow from Financing Activities of INDEGENE Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹288 Cr | Positive | |
| Mar2024 | ₹-66 Cr | Negative | |
| Mar2023 | ₹333 Cr | 42.67 | |
| Mar2022 | ₹233 Cr | Positive | |
| Mar2021 | ₹-132 Cr | - | |
Compare Cash Flow from Financing Activities of peers of INDEGENE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDEGENE | ₹10,464.0 Cr | 2.4% | -11.9% | -18.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,647.0 Cr | 0.1% | -0.4% | 0.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹157,862.0 Cr | -1.1% | -7.1% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,846.0 Cr | 0.2% | -4.5% | 30.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,720.0 Cr | 0.2% | -4% | 6% | Stock Analytics | |
| CIPLA | ₹98,795.9 Cr | 0% | -9.1% | -18.5% | Stock Analytics | |
INDEGENE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDEGENE | 2.4% |
-11.9% |
-18.1% |
| SENSEX | -3.5% |
-12.5% |
-6.5% |
You may also like the below Video Courses